Delivery Order SPE2DR25D6039-SPE2DR26FJ77P
- Not listed
- The Defense Logistics Agency awarded a $3,637.67 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count packaging). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical procurement falling under the company's larger federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,398.71 to AmerisourceBergen Drug Corp for Junel FE 1.5 mg-30 mcg tablets (28-count package). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency awarded a delivery order valued at $3,570.36 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages). This firm fixed price, non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,800.03 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages) on September 8, 2025, with completion expected by September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is classified as a child contract under a larger vehicle. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Junel FE 1.5 mg-30 mcg tablets (28-count packaging) under a firm fixed-price contract valued at $2,227.14. The order was competitively awarded without set-aside designation and is scheduled for completion by December 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $2,076.91 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on November 20, 2025, with completion targeted for November 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single pharmaceutical delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $1,772.81 to AmerisourceBergen Drug Corp for Junel FE 1.5 mg–30 mcg tablets (28-count packages) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets, with a contract ceiling value of $1,201.82. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a competitively awarded, non-set-aside procurement with performance taking place at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 19, 2025, for the supply of Junel FE 1 mg-20 mcg tablets in a 28-tablet package configuration. This firm fixed-price delivery order, valued at $1,141.06, represents a non-set-aside competitive award with an ultimate completion date of May 20, 2025. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DR25D6039Indefinite Delivery Contract
- SPE2DR25D6039-SPE2DR26FJ77PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,365.51 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages) under a firm fixed price contract. The award, issued on November 26, 2025, with an ultimate completion date of November 28, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/25/25 |